Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313

Recall Insight

This FDA Drug action (record #D-0332-2026) was formally reported on February 11, 2026, with the manufacturer initiating the action on December 22, 2025. It is classified under Critical severity (Class I), with a current status of Ongoing. HANDELNINE GLOBAL LLC is listed as the recalling firm, operating out of South Plainfield, NJ. Federal records indicate 4 bottles /30 capsules each units are affected.

The documented reason for this recall is: CGMP Deviations: product found to contain lead. Distribution data in the federal record shows the product reached: Product was distributed to one customer in NY.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

To put this record in context, PlainRecalls indexes 83,949 recalls across the FDA, CPSC, NHTSA and USDA FSIS going back to 1995. Within the same product category, the database holds 6 closely related recalls, of which 5 were also issued by FDA Drug. That clustering is a signal — repeated actions in a narrow category often indicate a systemic quality-control issue, a supplier-wide contamination, or a design defect that has propagated across product lines. Because this recall is recent, remedy windows and replacement inventory are most likely still actively available from the firm or retailer. Always cross-check the recall number against the official agency page before relying on any summary.